Skip to main content

Rare Lymphomas

  • Book
  • © 2014

Overview

  • Focuses on the rare lymphomas often not covered in other books
  • Provides a comprehensive overview of current treatment strategies
  • Emphasizes translation of molecular science into clinical care
  • Most chapters authored by pairs of American and European experts, representing worldwide standards

Part of the book series: Hematologic Malignancies (HEMATOLOGIC)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (19 chapters)

  1. General

  2. Disease-Specific: T-NHL

  3. Disease-Specific: B-NHL

Keywords

About this book

After a decade of tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma, optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors. Even more importantly, molecular targeted approaches have been shown to be effective in the treatment of distinct lymphoma subtypes. Against this background, clinical management of especially the rare lymphomas remains a challenge for the general oncologist. This book provides a comprehensive overview of current treatment strategies in these rare lymphoma subtypes. Experts in the field from around the world describe histomorphology in a clinically relevant manner, consider the role of risk factors in detail, and discuss the spectrum of therapeutic approaches. Special emphasis is placed on the translation of molecular science into clinical care, and a disease-specific algorithm is proposed for each entity.

Reviews

From the book reviews:

“Devoted to the rare or unusual subtypes of non-Hodgkin’s lymphoma (NHL), this book provides a comprehensive review of each subtype, including its natural history, pathogenesis, molecular biology, prognosis, management, and future directions. … The intended audience includes hematologists, oncologists, pathologists, established researchers, medical students, and residents, but the book is probably most useful for hematologists, oncologists, and pathologists. … It is a keeper, especially for those interested in lymphoma.” (Auayporn Nademanee, Doody’s Book Reviews, August, 2014)

Editors and Affiliations

  • Medizinischen Klinik und Poliklinik III, Universität München Klinikum Großhadern, München, Germany

    Martin Dreyling

  • Division of Hematology/Oncology and Cancer Center, University of Virginia Health System, Charlottesville, USA

    Michael E. Williams

Bibliographic Information

  • Book Title: Rare Lymphomas

  • Editors: Martin Dreyling, Michael E. Williams

  • Series Title: Hematologic Malignancies

  • DOI: https://doi.org/10.1007/978-3-642-39590-1

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2014

  • Hardcover ISBN: 978-3-642-39589-5Published: 27 February 2014

  • Softcover ISBN: 978-3-662-50772-8Published: 23 August 2016

  • eBook ISBN: 978-3-642-39590-1Published: 13 February 2014

  • Series ISSN: 2197-9766

  • Series E-ISSN: 2197-9774

  • Edition Number: 1

  • Number of Pages: X, 364

  • Number of Illustrations: 10 b/w illustrations, 70 illustrations in colour

  • Topics: Hematology, Oncology

Publish with us